These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 7102416)

  • 21. Role of calcium antagonists in cerebral arterial spasm.
    Allen GS
    Am J Cardiol; 1985 Jan; 55(3):149B-153B. PubMed ID: 3881907
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nonpeptide endothelin antagonist. Cerebrovascular characterization and effects on delayed cerebral vasospasm.
    Willette RN; Zhang H; Mitchell MP; Sauermelch CF; Ohlstein EH; Sulpizio AC
    Stroke; 1994 Dec; 25(12):2450-5; discussion 2456. PubMed ID: 7974589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brain ischaemia, calcium and calcium antagonists.
    Nowicki JP; MacKenzie ET; Young AR
    Pathol Biol (Paris); 1982 May; 30(5):282-8. PubMed ID: 7048220
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The nature of cerebral vasospasm.
    Mchedlishvili G
    Blood Vessels; 1981; 18(6):311-20. PubMed ID: 7034819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The relevance of in vitro smooth muscle experiments to cerebral vasospasm.
    Wellum GR; Peterson JW; Zervas NT
    Stroke; 1985; 16(4):573-81. PubMed ID: 3895590
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical application of Ca2(+)-antagonist for prevention and treatment of cerebral vasospasm].
    Kyoi K; Utsumi S
    Nihon Rinsho; 1989 Aug; 47(8):1831-6. PubMed ID: 2685399
    [No Abstract]   [Full Text] [Related]  

  • 27. Change in Ca2+ sensitivity of cerebrovascular smooth muscle in experimental chronic cerebral vasospasm.
    Tanaka Y; Masuzawa T; Saito M; Yamada T; Fujimoto K
    Neurol Med Chir (Tokyo); 1998 Aug; 38(8):459-63. PubMed ID: 9780642
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Calcium channel blockers for the treatment of coronary artery spasm: rationale, effects, and nursing responsibilities.
    Braun LT
    Heart Lung; 1983 May; 12(3):226-32. PubMed ID: 6551368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nimodipine and chronic vasospasm in monkeys: Part 2. Pharmacological studies of vessels in spasm.
    Krueger C; Weir B; Nosko M; Cook D; Norris S
    Neurosurgery; 1985 Feb; 16(2):137-40. PubMed ID: 3974823
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implications of nimodipine prophylaxis of cerebral vasospasm on anesthetic management during intracranial aneurysm clipping.
    Stullken EH; Johnston WE; Prough DS; Balestrieri FJ; McWhorter JM
    J Neurosurg; 1985 Feb; 62(2):200-5. PubMed ID: 3881564
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endothelin and subarachnoid hemorrhage: an overview.
    Zimmermann M; Seifert V
    Neurosurgery; 1998 Oct; 43(4):863-75; discussion 875-6. PubMed ID: 9766314
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Responses of isolated cerebral arteries to vasoactive agents.
    White RP
    Neurosurg Clin N Am; 1990 Apr; 1(2):401-15. PubMed ID: 2136151
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of nimodipine, a calcium antagonist, on cerebral vasospasm after subarachnoid hemorrhage in cats.
    Tanaka K; Gotoh F; Muramatsu F; Fukuuchi Y; Okayasu H; Suzuki N; Kobari M
    Arzneimittelforschung; 1982; 32(12):1529-34. PubMed ID: 6891592
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lazaroids and deferoxamine attenuate the intracellular effects of oxyhaemoglobin in vascular smooth muscle.
    Vollrath B; Chan P; Findlay M; Cook D
    Cardiovasc Res; 1995 Oct; 30(4):619-26. PubMed ID: 8575010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cerebral vasospasm caused by subarachnoid hemorrhage].
    Paoletti P; Gaetani P; Spanu G; Rodriguez y Baena R
    Minerva Med; 1986 Jun; 77(24):1071-7. PubMed ID: 3088488
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect and management of delayed vasospasm after aneurysmal subarachnoid hemorrhage.
    Dorsch NW
    Neurol Med Chir (Tokyo); 1998; 38 Suppl():156-60. PubMed ID: 10234999
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A study of ionized calcium in the whole blood of patients with subarachnoid hemorrhage].
    Abiko S; Yamashita T; Shiroyama Y; Aoki H
    Neurol Med Chir (Tokyo); 1991 Dec; 31(13):876-80. PubMed ID: 1726246
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Roles of subarachnoid blood clots and norepinephrine in cerebral vasospasm.
    Shigeno T; Saito I; Sano K; Takakura K; Brock M
    Acta Neurochir (Wien); 1982; 63(1-4):277-80. PubMed ID: 7102419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Calcium antagonists in the management of patients with aneurysmal subarachnoid hemorrhage: a review.
    Adams HP
    Angiology; 1990 Nov; 41(11 Pt 2):1010-6. PubMed ID: 2248423
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of calcium antagonist (diltiazem) on symptomatic cerebral vasospasm].
    Takagi T; Kuwahara M; Nagai H; Hotta K; Ozawa M; Nagatomi H
    Neurol Med Chir (Tokyo); 1986 Nov; 26(11):863-9. PubMed ID: 2437477
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.